milvexian
bms
['milvexian']
while the therapy, milvexian, showed a 30% risk reduction in recurrent ischemic strokes among people who showed symptoms, it didn't have an effect on covert infarcts, eroding investor confidence. 
Providing simple, jargon free, valuations on publicly traded companies (with asymmetrical risk/reward potential).